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Abstract. Oral cancer screening is important for early detection and early treatment,
which help improve survival rates. Biopsy is invasive and painful, while
fluorescence visualization using optical instruments is non-invasive, convenient,
and provides results in real time, and examinations can be repeated. The purpose of
this study was to determine the usefulness of optical instruments in oral screening. A
total of 314 patients who were examined using optical instruments at Tokyo Dental
College between 2014 and 2018 were enrolled in this study. Fluorescence
visualization images were analyzed using subjective and objective evaluations.
Subjective evaluation for detecting oral cancer offered 98.0% sensitivity and 43.2%
specificity. Regarding the objective evaluations for detecting oral cancer, sensitivity
and specificity were 61.9% and 62.7% for mean luminance, 90.3% and 55.7% for
luminance ratio, 56.5% and 67.7% for standard deviation of luminance, and 72.5%
and 85.4% for coefficient of variation of luminance. Fluorescence visualization with
subjective and objective evaluation using optical instruments is useful for oral
cancer screening.
Key words: oral squamous cell carcinoma; oral
potentially malignant disorder; optical instru-
ment; fluorescence visualization loss; medical
artificial intelligence.
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Oral and pharyngeal cancers represent a
global health challenge, with recently es-
timated incidence of over 657,000 newly
diagnosed cases and 330,000 fatal cases
each year1. In Japan, in particular, there
has been a tendency of increasing mortali-
ty2. More than 90% of oral cancers are
oral squamous cell carcinoma (SCC)3.
Delayed diagnosis accounts for poor qual-
ity of life and a high mortality rate, and
nearly half of SCC cases are at an ad-
vanced stage at the time of initial diagno-
sis3. Early detection and early treatment
are crucial to help improve the survival
rate of patients with SCC4.
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Oral screening plays a vital role in
making the correct decision about lesions,
and such screening is thus crucial in avoid-
ing unnecessary or delayed referrals and
considerably reducing the mortality of
SCC5. SCC may develop from an oral
potentially malignant disorder, such as
leukoplakia or oral lichen planus (OLP).
It has been reported that the early detec-
tion and management of oral epithelial
dysplasia (OED) in oral potentially malig-
nant disorder cases is an important pre-
ventative step against malignant
transformation6. During visual inspection
and palpation, a major limitation is the
difficulty in differentiating between be-
nign and high-risk lesions, as early-stage
SCC and OED may not present with typi-
cal features. Furthermore, a wide variety
of oral mucosal diseases can present in
various ways in the oral cavity7.
Although surgical biopsy is regarded as
the gold standard for oral cancer diagno-
sis, this process is invasive, time-consum-
ing, and painful8. Various other methods
for diagnosing SCC have emerged7.
Screening for SCC can involve cytology9,
vital staining10, and fluorescence visuali-
zation (FV)11. FV is a non-invasive, con-
venient, and real-time screening method
using optical instruments, and the exam-
inations can be repeated11,12. FV uses blue
light (400–460 nm) to illuminate collagen
cross-links or flavin adenine dinucleotide
(FAD) and nicotinamide adenine dinucle-
otide (NADH)12. A selective filter allows
the viewer to directly visualize the apple-
green autofluorescence given off by nor-
mal tissue (fluorescence visualization re-
tention, FVR). On the other hand,
abnormal tissues such as those seen in
SCC, OED, and inflammatory diseases
exhibit decreased autofluorescence and
appear as dark-brown areas in comparison
with the green surrounding normal tissue.
Such dark-brown areas are referred to as
FV loss (FVL)13. FVL is caused by ab-
sorption of a specific wavelength of blue
light due to the breakdown of collagen
cross-links and decreases in FAD and
NADH, and angiogenesis.
The evaluation of FV in studies per-
formed previously has been visual and
subjective. Therefore, definitive results
are lacking11. The purpose of this study
was to clarify the utility of subjective and
objective evaluations using optical instru-
ments for oral screening.
Materials and methods
A total of 314 patients attending the De-
partment of Oral and Maxillofacial Sur-
gery of Tokyo Dental College from
January 2014 to December 2018 were
enrolled in this study. Of the 314 partici-
pants, 162 were male and 152 were fe-
male, and their mean age was 68.3 years
(range 35–88 years). The inclusion criteria
were (1) patient examined using optical
instruments before treatment, (2) patient
provided informed consent to participate
in the study, and (3) a confirmed diagnosis
was obtained by biopsy, except for stoma-
titis. All patients with SCC were re-staged
using the eighth edition of the TNM Clas-
sification of Malignant Tumours of the
Union for International Cancer Control
(UICC)6. The study was approved by
the institutional review board and per-
formed in accordance with the require-
ments of the Declaration of Helsinki
(64th WMA General Assembly, Fortaleza,
Brazil, October 2013).
The optical instrument used in the ex-
amination protocol for each patient in this
study was either ORALOOK (Hits Plan
Inc., Tokyo, Japan) or IllumiScan (Shofu
Inc., Kyoto, Japan). These optical instru-
ments allow FV images to be taken and
saved to the camera as digital data. FV
images of the lesion can be observed in
real time because the optical instruments
have their own monitor. These lightweight
instruments can be used with one hand. FV
images were taken in a darkened room as
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Fig. 1. Methods of subjective and objective evaluation. In the subjective evaluation, oral photographs and FV images were compared (A, B), to
evaluate FVR or FVL in the lesions. The ROI of the lesion was defined as the area of FVL. The control ROI was set as a sub-site without FVL in the
same oral cavity, in the normal mucosa in front of the lesion (C). The state of the lesion ROI was expressed in a surface plot (D). (FV, fluorescence
visualization; FVR, fluorescence visualization retention; FVL, fluorescence visualization loss; ROI, region of interest.)
much as possible, with a distance between
the lesion and optical instrument of about
10 cm. The irradiating light was set per-
pendicular to the lesion and the irradiation
range was set to approximately 10 cm14.
In the subjective evaluations, oral
photographs and FV images were com-
pared to evaluate the FVR or FVL in the
lesions (Fig. 1A, B). FV images were
analyzed using ImageJ software version
1.5 (National Institutes of Health,
Bethesda, MD, USA). Regions of interest
(ROI) for the lesion and a control area
were established in the FV images14.
The ROI of the lesion was defined as the
area of FVL. The control ROI was set at a
distance from and in front of the ROI of
the lesion, in the same sub-site of the oral
cavity, in normal mucosa; there was no
FVL or oral mucosal lesion at this site
(Fig. 1C). The state of the lesion ROI was
expressed in a surface plot. In addition,
colour mapping was performed for the
surface plot of the lesion ROI (Fig. 1D).
The surface plot was used as a reference
for subjective evaluation14.
In the subjective evaluation, positive
cases were defined as those with FVL
and negative case as those with only
FVR; two or more examiners performed
this evaluation. The FVL rate was then
calculated. Sensitivity and specificity
were calculated as follows: sensitivity =
(FVL positive cases with SCC/all cases
with SCC)  100%; specificity = (FVL
negative cases without SCC/all cases
without SCC)  100%.
In the objective evaluation, the mean
area of the ROI (measured in pixels), mean
luminance (in candela per square metre,
cd/m2), standard deviation (SD) of lumi-
nance, coefficient of variation of lumi-
nance, and luminance ratio were
calculated. The coefficient of variation
of luminance was defined as the ratio of
the SD of luminance to the mean lumi-
nance. The luminance ratio was defined as
the ratio of the luminance of the lesion
ROI to the luminance of the control ROI; i.
e. luminance ratio = (ROI of lesion/ROI of
control) 100% 14.
For the differential diagnosis of oral
mucosal diseases, the x2 test, Mann–
Whitney U-test, and Fisher’s exact test
were used as statistical analyses. Cut-off
values were set using a receiver operating
characteristic (ROC) curve for detecting
SCC. The area under the curve (AUC),
sensitivity, and specificity were calculated
by ROC curve analysis. All statistical
analyses were performed using IBM SPSS
Statistics version 25.0 (IBM, Tokyo,
Japan). Values of P < 0.05 were deemed
statistically significant.
Results
Patient characteristics are shown in Table
1. Of the 314 patients, 24 had stomatitis,
18 had benign tumours, 98 had OLP, 73
had leukoplakia, and 101 had SCC. With
regard to sex, the male/female ratio was
10/14, 10/8, 38/60, 49/24, and 55/46, re-
spectively. Mean age was 62.9, 58.4, 63.8,
68.8, and 65.2 years, respectively. The
most common site for stomatitis, benign
tumour, leukoplakia, and SCC was the
tongue, while the most common site for
OLP was the buccal mucosa.
On histopathological diagnosis of the
stomatitis cases, 20 were found to have
catarrhal stomatitis and four to have viral
stomatitis. Patients with stomatitis did not
have any symptomatic disease, such as
Behçet disease, pemphigus, or pemphi-
goid. Sixteen of the patients with benign
tumours had fibroma, while two had lipo-
ma. With regard to the OLP patients, all
had chronic inflammation. Of the 73
patients with leukoplakia, hyperkeratosis
was seen in 62 patients and low-grade
OED in 11 patients. SCC grade 1 was
seen in 82 patients, while grade 2 was
seen in 12 patients and grade 3 in seven
patients.
Typical cases of each disease are shown
in Fig. 2. In stomatitis cases, a narrow and
uniform FVL was observed around fibrin,
and the boundaries of FVL were clear in
the FV images. In benign tumour cases, no
FVL was observed. For OLP, uniform
FVL was seen in the area of erythema,
the boundaries of FVL were clear, and FV
acceleration was observed in areas of leu-
koderma like lace. With leukoplakia, no
FVL was observed, but FV acceleration
was apparent. In the case of SCC, non-
uniform FVL was observed, and the
boundaries of FVL were unclear.
In the subjective evaluation, FVL/FVR
was 23/1 in stomatitis, 0/18 in benign
tumours, 87/11 in OLP, 11/62 in leuko-
plakia, and 99/2 in SCC. Therefore, the
FVL rate was 95.8% for stomatitis, 0.0%
for benign tumour, 88.8% for OLP, 15.1%
for leukoplakia, and 98.0% for SCC. All
leukoplakia with low-grade OED showed
FVL. SCC showed the highest FVL rate.
Subjective evaluation for detecting SCC
provided 98.0% sensitivity and 43.2%
specificity.
In the objective evaluation of the con-
trol sites, the mean area was within the
range of 839–893 pixels (P = 0.982),
mean luminance was 80.0–82.7 cd/m2
(P = 0.954), SD of luminance was 2.8–
3.4 (P = 0.964), and mean coefficient of
variation of luminance was 0.040–0.045
(P = 0.995). No significant differences
were observed in any items at the control
site.
In the objective evaluation of the lesion
site, the mean area was 34,884 pixels in
stomatitis cases, 71,742 pixels in benign
tumour cases, 113,267 pixels in OLP
cases, 109,873 pixels in leukoplakia cases,
and 160,731 pixels in SCC cases. Mean
luminance was 62.2 cd/m2 for stomatitis,
76.7 cd/m2 for benign tumours, 67.3 cd/
m2 for OLP, 85.2 cd/m2 for leukoplakia,
and 54.5 cd/m2 for SCC (Fig. 3). Mean
luminance was significantly higher in leu-
koplakia than in stomatitis or OLP (P =
0.032 and 0.021, respectively). Mean lu-
minance in SCC was significantly lower
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Table 1. Patient characteristics.
Stomatitis Benign tumour OLP Leukoplakia SCC
n = 24 n = 18 n = 98 n = 73 n = 101
Sex, male/female 10/14 10/8 38/60 49/24 55/46
Age, mean years 62.9 58.4 63.8 68.8 65.2
Site, n
Tongue 10 10 20 53 71
Buccal mucosa 3 8 56 8 9
Gingiva 2 0 18 2 13
Other 9 0 4 10 8
Control site, mean
Area (pixels) 893 839 857 846 862
Luminance (cd/m2) 80.0 81.2 81.7 82.7 80.8
Standard deviation 3.2 2.8 3.4 2.9 3.1
Coefficient of variation 0.042 0.040 0.043 0.041 0.045
Lesion site, mean
FVL rate, (%) 95.8% 0.0% 88.8% 15.1% 98.0%
Area (pixels) 34,884 71,742 113,267 109,873 160,731
Luminance (cd/m2) 62.2 76.7 67.3 85.2 54.5
Standard deviation 8.3 9.1 8.9 9.4 11.9
Coefficient of variation 0.13 0.12 0.13 0.13 0.22
Luminance ratio (%) 83.6% 99.0% 80.5% 109.0% 67.8%
OLP, oral lichen planus; SCC, squamous cell carcinoma; FVL, fluorescence visualization loss.
than in the other diseases (all P < 0.05).
SD of luminance was 8.3 for stomatitis,
9.1 for benign tumours, 8.9 for OLP, 9.4
for leukoplakia, and 11.9 for SCC (Fig. 4).
The SD of luminance was significantly
higher in SCC than in OLP or leukoplakia
(P = 0.008 and 0.007, respectively), and it
was significantly higher in benign tumours
than in OLP (P = 0.04). The coefficient of
variation of luminance was 0.13 for sto-
matitis, 0.12 for benign tumours, 0.13 for
OLP, 0.13 for leukoplakia, and 0.22 for
SCC, again showing a significantly higher
value for SCC than for the other diseases
(P < 0.001, Fig. 4). The luminance ratio
was 83.6% for stomatitis, 99.0% for be-
nign tumours, 80.5% for OLP, 109.0% for
leukoplakia, and 67.8% for SCC, showing
significant differences between all of the
diseases (P < 0.001, each, Fig. 3).
The objective evaluation for the detec-
tion of SCC by ROC curve analysis is
shown in Fig. 5. The AUC was 0.674
for mean luminance, 0.828 for luminance
ratio, 0.616 for SD of luminance, and
0.843 for coefficient of variation of lumi-
nance. Cut-off values were set at 60 cd/m2
for mean luminance, 86.8% for luminance
ratio, 9.1 for SD of luminance, and 0.18
for coefficient of variation of luminance.
Sensitivity and specificity were 61.9% and
62.7% for mean luminance, 90.3% and
55.7% for luminance ratio, 56.5% and
67.7% for SD of luminance, and 72.5%
and 85.4% for coefficient of variation of
luminance.
Discussion
Early diagnosis by general dentists is con-
sidered likely to improve the outcomes of
SCC. Screening should be minimally in-
vasive, repeatable, and inexpensive. Cy-
tology9, vital staining10, and FV11,14 are
simple and effective methods of screening
for SCC.
Oral brush cytology is a well-tolerated,
mildly invasive, safe approach for harvest-
ing cells from the oral mucosa9. However,
it takes several days for the results of oral
brush cytology to become available, and
the method offers 60–100% sensitivity
and 23.5–100% specificity9. Also, it is
difficult to detect hyperkeratotic lesions
with oral brush cytology9. Vital staining
with iodine solution in the oral cavity
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Fig. 2. Typical cases of each disease. The representative case of stomatitis with ulceration of the right tongue had a histopathological diagnosis of
catarrhal stomatitis. In the FV images, a narrow, uniform FVL is observed around fibrin, and the boundaries of FVL are clear. In the case of benign
tumour with fibroma of the left buccal mucosa, FVL is not evident. The case of OLP with a reticular lesion of the left buccal mucosa had a
histopathological diagnosis of OLP. In the FV images, uniform FVL is observed in the erythematous area, and the boundaries of FVL are clear. FV
acceleration is observed in areas of leukoderma. The case with leukoplakia with uniform leukoderma of the right tongue had a histopathological
diagnosis of hyperkeratosis. In the FV images, no FVL is apparent, although FV acceleration is present. The representative case of SCC with an
erosive lesion on the right tongue had a histopathological diagnosis of SCC grade 1. In the FV images, non-uniform FVL is observed, and the
boundaries of FVL are unclear. (FV, fluorescence visualization; FVL, fluorescence visualization loss; OLP, oral lichen planus; SCC, squamous
cell carcinoma.)
allows easy observation of the results in
real time. In cases of SCC and in low- and
high-grade OED, little glycogen is present
in the granule cell layer, resulting in a
relative lack of iodine staining. However,
iodine solution cannot be used for patients
with an iodine allergy, and the technique is
mildly invasive10. Iodine solution is useful
for movable mucosa such as the tongue,
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Fig. 4. Standard deviation of luminance and coefficient of variation of luminance as objective evaluations. SCC showed a significantly higher
standard deviation of luminance than OLP and leukoplakia. The coefficient of variation of luminance was 0.13 for stomatitis, 0.12 for benign
tumour, 0.13 for OLP, 0.13 for leukoplakia, and 0.22 for SCC, showing a significantly higher value for SCC than for the other diseases. (OLP, oral
lichen planus; SCC, squamous cell carcinoma.)
Fig. 3. Mean luminance and luminance ratio as objective evaluations. Leukoplakia showed significantly higher mean luminance than stomatitis
and OLP. SCC showed significantly lower mean luminance than the other diseases. All diseases showed significant differences in luminance ratio.
(OLP, oral lichen planus; SCC, squamous cell carcinoma.)
oral floor, buccal mucosa, and soft palate,
but is difficult to use on keratinized mu-
cosa such as the gingiva and hard palate10.
Iodine solution offers 71–87.5% sensitivi-
ty and 84.2% specificity10,15,16.
FV with optical instruments is non-in-
vasive, convenient, provides results in real
time, and examinations can be repeat-
ed11,12. This technique can be adapted
for use anywhere in the oral cavity. ORA-
LOOK is a lightweight and simple instru-
ment with a built-in filter. It captures both
FV images and oral photographs. This
optical instrument irradiates the target
with blue light at an excitation wavelength
of about 410 nm and detects only apple-
green fluorescence via the filter (520–560
nm). IllumiScan is also a lightweight and
simple instrument with a built-in filter.
However, it captures only FV images. This
optical instrument irradiates the target
with blue light at an excitation wavelength
of about 425 nm, while it detects only
apple-green fluorescence via the filter
(470–580 nm). These optical instruments
were selected for this study because they
detect a single green fluorescence colour
and image processing analysis is simple.
The evaluation of FV in previous stud-
ies was subjective, varying depending on
the report11. In the present study, subjec-
tive evaluation for the detection of SCC
showed high sensitivity (98.0%) and low
specificity (43.2%). These factors include
FVL in inflammatory diseases17. Thus, it
was considered that a new evaluation
method was necessary in order to obtain
an objective evaluation.
In terms of discriminating between var-
ious oral mucosal diseases, mean lumi-
nance was significantly lower in SCC than
in the other diseases; however, all diseases
were difficult to distinguish by mean lu-
minance as an objective evaluation. Al-
though the protocol was kept constant in
this study, some degree of influence from
environmental factors cannot be ruled
out14. Using the luminance ratio, the in-
fluence of environmental factors is re-
duced; in this way it was possible to
discriminate the individual oral diseases
from each other. SCC has been reported to
show intratumoural heterogeneity18. The
SD of luminance and coefficient of varia-
tion of luminance were significantly
higher in SCC cases than in benign
lesions14. Each objective evaluation
showed significant results, suggesting
their effectiveness. Semi-quantitative
methods can eliminate differences be-
tween institutions and can facilitate more
uniform medical treatment.
The Oral Cancer Navigation System
(Navi-System) was introduced into the
Department of Oral and Maxillofacial Sur-
gery of Tokyo Dental College, Japan in
2012. The Navi-System allows medical
cooperation via the Internet19. Also, in
recent years, many reports have described
the potential application of artificial intel-
ligence (AI) across the medical fields20.
We are considering next-generation oral
cancer screening with medical AI by ac-
cumulating cases and using objective eva-
luations in the future.
This study revealed the utility of sub-
jective and objective evaluations in oral
cancer screening using an optical instru-
ment. Oral cancer screening using an op-
tical instrument can effectively facilitate
the early detection of SCC and OED. By
adding an optical instrument to the Navi-
System, we believe that high-quality med-
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Fig. 5. Objective evaluation from ROC curve analysis. In terms of AUC, the coefficient of variation of luminance showed the highest value,
followed by the luminance ratio. The sensitivity and specificity are 61.9% and 62.7% for mean luminance, 90.3% and 55.7% for the luminance
ratio, 56.5% and 67.7% for the standard deviation of luminance, and 72.5% and 85.4% for the coefficient of variation of luminance. (ROC, receiver
operating characteristic; AUC, area under the curve.)
Ethical approval
This study was approved by the Ethics
Committee of Tokyo Dental College (au-
thorization number 740).
Patient consent
Consent was obtained from all participants
in this study.
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